Cargando…

Role of hormones in hypoactive sexual desire disorder and current treatment

Over the decades, female sexual dysfunction (FSD) has grown to be an increasingly potential problem that complicates the quality of life among women. In the current review, FSD refers to recurrent and persistent problems with sexual orgasm, desire, or response. One of the most common subtypes of FSD...

Descripción completa

Detalles Bibliográficos
Autores principales:	AlAwlaqi, Ahmed, Amor, Houda, Hammadeh, Mohamed E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776161/ https://www.ncbi.nlm.nih.gov/pubmed/29278235 http://dx.doi.org/10.4274/jtgga.2017.0071

Ejemplares similares

Flibanserin for Treating Hypoactive Sexual Desire Disorder
por: Sang, Jae Hong, et al.
Publicado: (2016)

Evaluation and Management of Hypoactive Sexual Desire Disorder
por: Clayton, Anita H., et al.
Publicado: (2018)

Management of hypoactive sexual desire disorder in women: current and emerging therapies
por: Nappi, Rossella E, et al.
Publicado: (2010)

Bremelanotide for Treatment of Female Hypoactive Sexual Desire
por: Edinoff, Amber N., et al.
Publicado: (2022)

Hypoactive sexual desire disorder caused by antiepileptic drugs
por: Singh, M., et al.
Publicado: (2015)

Women and Men’s Perspectives on the Factors Related to Women’s Dyadic Sexual Desire, and on the Treatment of Hypoactive Sexual Desire Disorder
por: Friedmann, Enav, et al.
Publicado: (2021)

Reliability and validity of the elements of desire questionnaire in premenopausal women with hypoactive sexual desire disorder
por: Revicki, Dennis A., et al.
Publicado: (2020)

New developments in the treatment of hypoactive sexual desire disorder – a focus on Flibanserin
por: Jayne, Christopher J, et al.
Publicado: (2017)

Flibanserin: A controversial drug for female hypoactive sexual desire disorder
por: Baid, Rashmi, et al.
Publicado: (2018)

Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder
por: Simon, James A., et al.
Publicado: (2019)

Psychometric Properties of the Sexual Interest and Desire Inventory-Female for Diagnosis of Hypoactive Sexual Desire Disorder: The Persian Version
por: Malary, Mina, et al.
Publicado: (2016)

Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials
por: Kingsberg, Sheryl A., et al.
Publicado: (2019)

A Practical Approach to Managing Hypoactive Sexual Desire Disorder in Women with Diabetes
por: Rochester-Eyeguokan, Charmaine, et al.
Publicado: (2017)

Clinically Meaningful Benefit in Women with Hypoactive Sexual Desire Disorder Treated with Flibanserin
por: Simon, James A., et al.
Publicado: (2022)

Assessing the Burden of Illness Associated with Acquired Generalized Hypoactive Sexual Desire Disorder
por: Simon, James A., et al.
Publicado: (2022)

Socio-demographic determinants of low sexual desire and hypoactive sexual desire disorder: a population-based study in Iran
por: Hamzehgardeshi, Zeinab, et al.
Publicado: (2020)

Systematic Review of l-Arginine for the Treatment of Hypoactive Sexual Desire Disorder and Related Conditions in Women
por: Cieri-Hutcherson, Nicole E., et al.
Publicado: (2021)

What Sexual Behaviors Relate to Decreased Sexual Desire in Women? A Review and Proposal for End Points in Treatment Trials for Hypoactive Sexual Desire Disorder
por: Pyke, Robert, et al.
Publicado: (2016)

The Effect of Education on Sexual Health of Women with Hypoactive Sexual Desire Disorder: A Randomized Controlled Trial
por: Kaviani, Maasumeh, et al.
Publicado: (2014)

Melanocortin 4 receptor agonism enhances sexual brain processing in women with hypoactive sexual desire disorder
por: Thurston, Layla, et al.
Publicado: (2022)

Effects of Flibanserin on Subdomain Scores of the Female Sexual Function Index in Women With Hypoactive Sexual Desire Disorder
por: Simon, James A., et al.
Publicado: (2022)

PMON214 Kisspeptin Restores Sexual and Attraction Brain Processing in Women with Hypoactive Sexual Desire Disorder
por: Thurston, Layla, et al.
Publicado: (2022)

Characteristics of Chinese women in need of enhanced sexual health attention and at risk of hypoactive sexual desire disorder
por: Luo, Lan, et al.
Publicado: (2023)

BIOPSYCHOSOCIAL DETERMINANTS OF HYPOACTIVE SEXUAL DESIRE IN WOMEN: A NARRATIVE REVIEW
por: Malary, Mina, et al.
Publicado: (2015)

Acupuncture in Premenopausal Women With Hypoactive Sexual Desire Disorder: A Prospective Cohort Pilot Study
por: Oakley, Susan H., et al.
Publicado: (2016)

Differences in the Gut Microbiome of Women With and Without Hypoactive Sexual Desire Disorder: Case Control Study
por: Li, Guanjian, et al.
Publicado: (2021)

Body Image and Hypoactive Sexual Desire Disorder Relationship in a Representative Sample of Iranian Women
por: Hamzehgardeshi, Zeinab, et al.
Publicado: (2020)

Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial
por: Thurston, Layla, et al.
Publicado: (2022)

Management of hypoactive sexual desire disorder in women in the gynecological setting: Number 5 - May 2021
por: Lara, Lucia Alves da Silva, et al.
Publicado: (2021)

OR17-5 Kisspeptin Increases Penile Tumescence and Sexual Brain Processing in Men with Hypoactive Sexual Desire Disorder
por: Abbara, Ali, et al.
Publicado: (2022)

The clinical management of testosterone replacement therapy in postmenopausal women with hypoactive sexual desire disorder: a review
por: Uloko, Maria, et al.
Publicado: (2022)

Low prolactin level identifies hypoactive sexual desire disorder women with a reduced inhibition profile
por: Maseroli, E., et al.
Publicado: (2023)

Effects of Kisspeptin on Sexual Brain Processing and Penile Tumescence in Men With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial
por: Mills, Edouard G., et al.
Publicado: (2023)

Effect of Flibanserin Treatment on Body Weight in Premenopausal and Postmenopausal Women with Hypoactive Sexual Desire Disorder: A Post Hoc Analysis
por: Kornstein, Susan G., et al.
Publicado: (2017)

Cognitive-behavioral group therapy for women with hypoactive sexual desire: A pilot randomized study
por: Lerner, Théo, et al.
Publicado: (2022)

International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
por: Parish, Sharon J., et al.
Publicado: (2021)

RF01 | PMON43 Melanocortin-4 Receptor Agonism Enhances Sexual Brain Processing in Women with Hypoactive Sexual Desire Disorder
por: Thurston, Layla, et al.
Publicado: (2022)

118: THE ASSOCIATION BETWEEN BODY IMAGE AND HYPOACTIVE SEXUAL DESIRE DISORDER AMONG REPRODUCTIVE AGE WOMEN: AN IRANIAN SETTING
por: Hamzehgardeshi, Zeinab, et al.
Publicado: (2017)

Scalable flibanserin nanocrystal-based novel sublingual platform for female hypoactive sexual desire disorder: engineering, optimization adopting the desirability function approach and in vivo pharmacokinetic study
por: Naguib, Marianne J., et al.
Publicado: (2021)

Transdermal Testosterone in Female Hypoactive Sexual Desire Disorder: A Rapid Qualitative Systematic Review Using Grading of Recommendations Assessment, Development and Evaluation
por: Ganesan, Kavitha, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ro87f71o7b37a53u204kvgc8eu